学術情報 -AJRCCM(ブルージャーナル)-

2019年03月 -PART 02-

慢性閉塞性肺疾患(COPD)のウイルスによる増悪は大気中の窒素酸化物濃度の上昇に伴って増加する

Increased Chronic Obstructive Pulmonary Disease Exacerbations of Likely Viral Etiology Follow Elevated Ambient Nitrogen Oxides
Am J Respir Crit Care Med 2019; 199(5): 581‒591

重症慢性閉塞性肺疾患(COPD)では肺リンパ濾胞におけるIgAの発現が上昇している

Increased IgA Expression in Lung Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease
Am J Respir Crit Care Med 2019; 199(5): 592‒602

オメガ-3脂肪酸とのゲノムワイド相互作用解析はDPP10遺伝子と肺機能との関連性を明らかにする

Omega-3 Fatty Acids and Genome-Wide Interaction Analyses Reveal DPP10‒Pulmonary Function Association
Am J Respir Crit Care Med 2019; 199(5): 631‒642

2019年03月 -PART 01-

イングランドの成人喘息患者の増悪パターン:集団ベース研究

Exacerbation Patterns in Adults with Asthma in England
A Population-based Study
Am J Respir Crit Care Med 2019; 199 (4): 446‒453

重症喘息では遠隔でICS治療を反映する一酸化窒素抑制状況をモニタリングすることにより治療ノンアドヒアランスを特定できる

Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma
Am J Respir Crit Care Med 2019; 199 (4): 454‒464

抗IL-5療法は軽症喘息においてライノウイルス誘発性のマクロファージ、B細胞及び好中球の応答を変化させる(MATERIAL) : プラセボ対照二重盲検試験

Anti‒IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL)
A Placebo-controlled, Double-Blind Study
Am J Respir Crit Care Med 2019; 199 (4): 508‒517

Selected articles from AJRCCM. Copyright 2018 by the American Thoracic Society. All rights reserved. The ideas and opinions expressed in the American Journal of Respiratory and Critical Care Medicine (AJRCCM) or other associated publications do not necessarily reflect those of the American Thoracic Society (ATS). The authors, editors or ATS are not responsible for errors or omissions of articles published in print or online from AJRCCM or other associated ATS publications. Although great care has been taken in compiling the content of this publication, neither ATS or their servants are responsible or liable in any way for the currency of the information, for any errors, omissions or inaccuracies, or for any consequences arising there from. Approved product information should be reviewed before prescribing. The mention of any product, service, or therapy in this publication should not be construed as an endorsement of the products mentioned. It is the responsibility of the treating physician or other health care provider, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient. Readers are advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify the dosage, method, and duration of administration, or contraindications. Readers are also encouraged to contact the manufacturer with questions about the features or limitations of any products. ATS assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in this publication or to any errors or omissions. 

The translation is © 2018 American Thoracic Society. American Thoracic Society or Springer Healthcare takes no responsibility for the accuracy of the translation from the published English original and are not liable for any errors that may occur.